ADH-1 in the treatment of metastatic adrenocortical carcinoma--case report.

Abstract:

:Adrenocortical Carcinoma (ACC) is rare with an annual incidence of 0.5-2 cases per million worldwide. Some ACC tumors over express N-cadherin, which correlates with metastatic potential. ADH-1 (Exherin™) is a competitive inhibitor of N-cadherin, resulting in rapid onset of tumor vascular angiolysis and apoptosis in preclinical models. Targeting N-cadherin may cause direct anti-tumor and anti-vascular effects. We report a case of ACC with benefit from ADH-1 therapy. A 24 year old woman with an N-cadherin expressing metastatic ACC was treated on a phase I trial and treated with ADH-1 subsequently received additional doses through a special access program. The patient presented with cushingoid features from cortisol over-secretion and was diagnosed with metastatic ACC in January 2003. Tumor progression followed treatment with a combination of doxorubicin, cisplatin and mitotane. In October 2003, as a part of a phase I clinical trial she was treated with as a single dose of ADH-1 at 150 mg/m(2). This resulted in transient normalization of cortisol, tumor necrosis on CT imaging, and reduction in tumor perfusion on DCE-MRI. Following progression on several additional lines of chemotherapy, she was again treated with ADH-1 under a Special Access Program (SAP). After 33 weekly doses (22 with 150 mg/m(2) and 11 with 300 mg/m(2)) radiographic tumor progression was demonstrated and treatment discontinued. She survived 40 months with metastatic disease, dying 12 months after her last dose of ADH-1. This observation merits consideration for prospectively evaluating the efficacy of ADH-1 in patients with cortisol secreting ACC that over express N-cadherin.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Yarom N,Stewart D,Avruch L,Malik R,Wells J,Jonker DJ

subject

Has Abstract

pub_date

2011-11-01 00:00:00

pages

3921-5

issue

11

eissn

0250-7005

issn

1791-7530

pii

31/11/3921

journal_volume

31

pub_type

杂志文章
  • Predicting response to therapy of squamous cell carcinoma of the head and neck (review).

    abstract::The design of treatment for patients with squamous cell carcinoma of the head and neck (SCCHN) is based on prognostic factors, today essentially performance status and TNM status. It becomes increasingly important to optimise treatment and find the appropriate level of treatment and resource consumption for each patie...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Wennerberg J

    更新日期:1996-07-01 00:00:00

  • The likely role of vitamin D from solar ultraviolet-B irradiance in increasing cancer survival.

    abstract:BACKGROUND:Solar ultraviolet-B (UVB) and vitamin D have been found inversely correlated with cancer incidence, mortality, and survival rates in many studies. MATERIALS AND METHODS:In this work, two sets of cancer data were used: age-adjusted cancer incidence and mortality rates in 2002 for 21 Western developed countri...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Grant WB

    更新日期:2006-07-01 00:00:00

  • Comparative immunological analysis of innate immunity activation after oral administration of wheat fermented extract to teleost fish.

    abstract:BACKGROUND:Intradermal or oral administration of lipopolysaccharide derived from Pantoea agglomerans (IP-PA1) has shown prophylactic and antitumor effects without serious side-effects. While it is known that tumor necrosis factor (TNF)-alpha produced by activated macrophages plays an important role in the expression me...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kadowaki T,Yasui Y,Takahashi Y,Kohchi C,Soma G,Inagawa H

    更新日期:2009-11-01 00:00:00

  • Prediction of Non-sentinel Lymph Node Metastases After Positive Sentinel Lymph Nodes Using Nomograms.

    abstract:BACKGROUND/AIM:Only 30-50% of patients with sentinel lymph node (SLN) metastases present with further axillary lymph node metastases. Therefore, up to 70% of patients with positive SLN are overtreated by axillary dissection (AD) and may suffer from complications such as sensory disturbances or lymphedema. According to ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12694

    authors: Gruber I,Henzel M,Schönfisch B,Stäbler A,Taran FA,Hahn M,Röhm C,Helms G,Oberlechner E,Wiesinger B,Nikolaou K,LA Fougère C,Wallwiener D,Hartkopf A,Krawczyk N,Fehm T,Brucker S

    更新日期:2018-07-01 00:00:00

  • In Vitro Study of the Anti-cancer Effect of Alternate-day 5-Fluorouracil in Head and Neck Cancer Cells.

    abstract:BACKGROUND/AIM:We have previously reported that alternate-day S-1 had comparable effects and milder adverse events than the respective consecutive-day regimen in head and neck cancer (HNC) patients. The aim of this study was to investigate the anticancer effects of both regimens and underlying mechanisms in vitro. MAT...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13810

    authors: Moro Y,Kogashiwa Y,Sakurai H,Takahashi R,Kimura T,Hirasaki M,Matsumoto Y,Sugasawa M,Kohno N

    更新日期:2019-11-01 00:00:00

  • Lower Esophageal Sphincter-preserving Anastomosis Is an Acceptable Reconstruction Method Following Laparoscopy-assisted Proximal Gastrectomy.

    abstract:BACKGROUND/AIMS:Our study aimed to compared 3-year results following laparoscopy-assisted proximal gastrectomy (LAPG)-double tract anastomosis (DTA) and lower esophageal sphincter-preserving LAPG (LES-LAPG). PATIENTS AND METHODS:Nine patients who underwent LES-LAPG and 23 LAPG-DTA were compared regarding 3-year follow...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13129

    authors: Kim DJ,Kim W

    更新日期:2019-01-01 00:00:00

  • Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.

    abstract:BACKGROUND:Combination chemotherapy of irinotecan and amrubicin for advanced non-small cell lung cancer (NSCLC) has not been fully evaluated. To determine the maximum-tolerated dose (MTD), a phase I study in patients with advanced NSCLC was conducted. MATERIALS AND METHODS:Patients with stage IIIB/IV NSCLC were enroll...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Hotta K,Takigawa N,Kiura K,Tabata M,Umemura S,Ogino A,Uchida A,Bessho A,Segawa Y,Shinkai T,Nogami N,Harita S,Okimoto N,Ueoka H,Tanimoto M

    更新日期:2005-05-01 00:00:00

  • Nuclear grooves in fine needle aspiration (FNA) biopsies of breast lesions.

    abstract::The present study was undertaken to evaluate the significance of grooved nuclei as an additional diagnostic criterion for primary breast carcinoma as well as their association with tumor grade in cytologic material obtained by fine needle aspiration (FNA). Cytologic slides of 105 cases of breast carcinoma (89 ductal, ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Labropoulou P,Psachoulia C,Batistatou A,Kardari M,Scopa CD

    更新日期:1996-11-01 00:00:00

  • Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer.

    abstract:BACKGROUND:The overexpression of syndecan-1 in breast carcinomas correlates with poorer prognosis and an aggressive phenotype. The effect of syndecan-1 expression on tumor response to neoadjuvant chemotherapy was determined in locally advanced breast cancer. PATIENTS AND METHODS:Semi-quantitative syndecan-1 immunohist...

    journal_title:Anticancer research

    pub_type: 杂志文章,随机对照试验

    doi:

    authors: Götte M,Kersting C,Ruggiero M,Tio J,Tulusan AH,Kiesel L,Wülfing P

    更新日期:2006-01-01 00:00:00

  • Postoperative radiotherapy for localized prostate cancer: clinical significance of nadir prostate-specific antigen value within 12 months.

    abstract:AIM:To analyze retrospectively the results of postoperative radiotherapy for localized prostate cancer and to investigate the clinical significance of nadir prostate-specific antigen (PSA) value within 12 months (nPSA12) as an early estimate of clinical outcome after radiotherapy. PATIENTS AND METHODS:Seventy-six pati...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ogawa K,Nakamura K,Sasaki T,Onishi H,Koizumi M,Araya M,Mukumoto N,Mitsumori M,Teshima T,Japanese Patterns of Care Study Working Subgroup of Prostate Cancer.

    更新日期:2009-11-01 00:00:00

  • Development of an animal model for prostate cancer cell metastasis to adult human bone.

    abstract:BACKGROUND:Prostate cancer metastases to bone are associated with significant morbidity and mortality. Presently, there is little known about the biological interaction between prostate cancer cells and bone. Development of an animal model using adult human bone will enhance our ability to study the biology of prostate...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tsingotjidou AS,Zotalis G,Jackson KR,Sawyers C,Puzas JE,Hicks DG,Reiter R,Lieberman JR

    更新日期:2001-03-01 00:00:00

  • Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.

    abstract:BACKGROUND:Tenascin-C (TNC) is an extracellular matrix glycoprotein, usually derived from myofibroblasts in the cancer microenvironment. Recently, however, the significance of tumor-derived TNC in initiation of cancer metastasis was disclosed. We investigated the clinical significance of cancer-derived TNC in colorecta...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Takahashi Y,Sawada G,Kurashige J,Matsumura T,Uchi R,Ueo H,Ishibashi M,Takano Y,Akiyoshi S,Iwaya T,Eguchi H,Sudo T,Sugimachi K,Yamamoto H,Doki Y,Mori M,Mimori K

    更新日期:2013-05-01 00:00:00

  • Cancer-associated alteration of circadian rhythms in carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in humans.

    abstract::A circadian rhythm of serum concentrations of two tumor markers (CEA and AFP) was demonstrated in individuals not suffering from cancer. These rhythms exhibited a diurnal peak with a nocturnal dip. They disappeared in cancer groups. However, in some cancer subjects, a circadian activity was still detectable, but with ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Focan C,Focan-Henrard D,Collette J,Mechkouri M,Levi F,Hrushesky W,Touitou Y,Franchimont P

    更新日期:1986-09-01 00:00:00

  • Radioimmunoassisted follow-up and surgery vs traditional examinations and surgery after radical excision of colorectal cancer.

    abstract::The authors report their experience in the radioimmunodetection of recurrent colorectal cancer in comparison with traditional examinations. 485 patients were studied after radical surgery for colorectal cancer: 168 (Group 1) were studied with a radioimmunoassisted follow-up plan including: Immunoscintigraphy (IS), ser...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Prati U,Roveda L,Cantoni A,Saponaro R,Bosi F,Sandolo R,Zonta A

    更新日期:1995-05-01 00:00:00

  • Effect of 5-fluorouracil on carcinoembryonic antigen expression and shedding at clonal level in colon cancer cells.

    abstract:BACKGROUND:The carcinoembryonic antigen (CEA) is a tumor marker largely utilized for the detection of minimal disease or as a target of immunotherapeutic approaches. In preclinical models CEA has been found to be up-regulated after exposure of cancer cells to 5-fluorouracil (5-FU). In the present study, the clonal dist...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Aquino A,Prete SP,Guadagni F,Greiner JW,Giuliani A,Orlando L,Masci G,De Santis S,Bonmassar E,Graziani G

    更新日期:2000-09-01 00:00:00

  • Effect of genistein on p90RSK phosphorylation and cell proliferation in T47D breast cancer cells.

    abstract:BACKGROUND:The molecular mechanisms of genistein's proliferative effects on breast cancer cells are largely unknown. This study aimed to examine estrogen-receptor (ER)-related signaling molecules involved in genistein-associated cell proliferation and survival (ERK1/2, p90RSK, JNK, Akt and NFκB) and to correlate these ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gwin J,Drews N,Ali S,Stamschror J,Sorenson M,Rajah TT

    更新日期:2011-01-01 00:00:00

  • Evidence of a direct relationship between the increase in the in vitro passage number of human non-small-cell-lung cancer primocultures and their chemosensitivity.

    abstract::A pharmacologically relevant modelling was attempted for screening of new molecules potentially active against non-small-cell lung cancers (NSCLCs). It was in this way that we investigated the in vivo chemosensitivity firstly of three human NSCLCs grafted onto nude mice, secondly of their in vitro primocultures, and t...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kruczynski A,Kiss R

    更新日期:1993-03-01 00:00:00

  • Elderly woman with triple-negative metastatic breast cancer successfully treated with metronomic capecitabine.

    abstract::Triple-negative breast cancer phenotype (estrogen receptor-, progesterone receptor- and human epidermal growth receptor 2-negative) is one of the most aggressive molecular subtypes, accounting for 15-20% of all breast tumors. There is no standard treatment for this setting of patients except anthracyclines and taxanes...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: De Iuliis F,Salerno G,Taglieri L,Vicinanza R,Lanza R,Scarpa S

    更新日期:2014-08-01 00:00:00

  • D-dimer elevation and paresis predict thromboembolic events during bevacizumab therapy for recurrent malignant glioma.

    abstract:BACKGROUND:The major side-effects of bevacizumab in glioma treatment are venous thromboembolic events (VTE). We retrospectively evaluated factors potentially predictive of thromboembolic events. PATIENTS AND METHODS:Bevacizumab, alone or in combination with chemotherapy was used as salvage therapy for recurrence in ma...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Misch M,Czabanka M,Dengler J,Stoffels M,Auf G,Vajkoczy P,Stockhammer F

    更新日期:2013-05-01 00:00:00

  • Clinical trials in disseminated malignant melanoma.

    abstract::At present the available treatment modalities are not therapeutic for disseminated stage III- and IV melanoma. The management of these patients therefore concentrates primarily on effective palliation taking care to improve the quality of life. As an exception from this rule, patients with regional or solitary metasta...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Kleeberg UR

    更新日期:1987-05-01 00:00:00

  • Oestrogen and progesterone receptor expression in patients with adenocarcinoma of the uterine cervix and correlation with various clinicopathological parameters.

    abstract:OBJECTIVE:The expression of oestrogen and progesterone receptors in patients with adenocarcinoma of the uterine cervix was examined in order to determine their influence on prognosis and to evaluate the association between the steroid receptor expression and various clinicopathologic parameters. PATIENTS AND METHODS:O...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bodner K,Laubichler P,Kimberger O,Czerwenka K,Zeillinger R,Bodner-Adler B

    更新日期:2010-04-01 00:00:00

  • Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma.

    abstract::To investigate the specific transduction of a suicide gene into human small cell lung carcinoma (SCLC) cells, we explored the promoter region of the neuron specific enolase (NSE) gene as a tumor-specific promoter. In Northern blot analysis, NSE mRNA was expressed more abundantly in the SBC3 human SCLC cell line than i...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tanaka M,Inase N,Miyake S,Yoshizawa Y

    更新日期:2001-01-01 00:00:00

  • Combined extraction techniques of tumour cells and lipid/phospholipid assignment by two dimensional NMR spectroscopy.

    abstract::As the cell membranes are one of the targets of drug treatment in cancer cells, their membrane composition and variations in this composition need to be analyzed. Gradient selected 2D-NMR inverse heteronuclear chemical shift correlations are have described, which offer optimum sensitivity combined with a high reliabil...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Henke J,Willker W,Engelmann J,Leibfritz D

    更新日期:1996-05-01 00:00:00

  • Tissue polypeptide antigen (TPA): usefulness in urological neoplasia.

    abstract::Urine and serum samples from a group of 359 individuals were studied in order to evaluate the usefulness of TPA in patients with urological cancers. Serum was taken from 110 people at 12 noon (S1), 5 pm (S2), and 8 am the following day (S3), while urine samples were collected from 73 individuals over three time interv...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Costello CB,Kumar S

    更新日期:1986-07-01 00:00:00

  • Preparation and biological characterization of conjugates consisting of ricin and a tumor-specific non-internalizing MAb.

    abstract::MOv18, a non-internalizing monoclonal antibody (MAb) with restricted tumor specificity, was conjugated to ricin toxin (RT). According to their ability to bind to galactose residues of Sepharose 6B, the immunoconjugates were fractionated into Bound and Unbound MOv18-RT. The two conjugates could be distinguished by SDS-...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Cogliati T,Brusa P,Canevari S,Caldera M,Mezzanzanica D,Dosio F,Cattel L,Colnaghi MI

    更新日期:1991-01-01 00:00:00

  • Long-term outcome of postorchiectomy radiation therapy for stage I and II testicular seminoma.

    abstract::To evaluate the treatment-related late sequelae including gonadal function and second malignancy 94 patients with stage I and II testicular seminoma treated with postorchiectomy radiation therapy were analyzed retrospectively. The 10-year cause specific, disease free and actuarial survival rates were 100, 98.5 and 96....

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Akimoto T,Takahashi I,Takahashi M,Yamakawa M,Hayakawa K,Mitsuhashi N,Niibe H

    更新日期:1997-09-01 00:00:00

  • Selective cytotoxic activity of grape peel and seed extracts against oral tumor cell lines.

    abstract::Grape seed extracts were more cytotoxic than grape peel extracts. Methanol and 70% methanol extracts of grape seed selectively killed two human oral tumor cell lines, more efficiently than human gingival fibroblasts. ESR spectroscopy revealed that these extracts produced radicals under alkaline conditions and enhanced...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Shirataki Y,Kawase M,Saito S,Kurihara T,Tanaka W,Satoh K,Sakagami H,Motohashi N

    更新日期:2000-01-01 00:00:00

  • Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma.

    abstract:UNLABELLED:Gastric carcinoma occurs in response to chronic inflammation of gastric mucosa infected with Helicobacter pylori. It is not known how cytokines affect the growth and progression of gastric carcinoma. MATERIALS AND METHODS:We measured tissue concentrations of the proinflammatory cytokines interleukin (IL)-1b...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kai H,Kitadai Y,Kodama M,Cho S,Kuroda T,Ito M,Tanaka S,Ohmoto Y,Chayama K

    更新日期:2005-03-01 00:00:00

  • Role of DNA Methylation in Cabazitaxel Resistance in Prostate Cancer.

    abstract:BACKGROUND/AIM:Cabazitaxel is an approved second-line treatment for docetaxel-refractory metastatic castration-resistant prostate cancer. However, the median time to progression on cabazitaxel is 2.8 months. We aimed to determine whether DNA methylation plays a role in cabazitaxel resistance. MATERIALS AND METHODS:DU1...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ramachandran K,Speer C,Nathanson L,Claros M,Singal R

    更新日期:2016-01-01 00:00:00

  • Tissue Biomarkers in Predicting Response to Sunitinib Treatment of Metastatic Renal Cell Carcinoma.

    abstract:AIM:To identify tissue biomarkers that are predictive of the therapeutic effect of sunitinib in treatment of metastatic clear cell renal cell carcinoma (mCRCC). MATERIALS AND METHODS:Our study included 39 patients with mCRCC treated with sunitinib. Patients were stratified into two groups based on their response to su...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Trávníček I,Branžovský J,Kalusová K,Hes O,Holubec L,Pele KB,Ürge T,Hora M

    更新日期:2015-10-01 00:00:00